Blog
RSS FeedPosted by Michael Wonder on 19 Sep 2019
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
18 September 2019 - In this study, the investigators examined the characteristics of randomised controlled trials that supported approval of cancer ...
Posted by Michael Wonder on 10 Sep 2019
For drug companies, there are real costs to unpopularity
10 September 2019 - A familiar headache for drug investors is likely to soon reappear. ...
Posted by Michael Wonder on 10 Sep 2019
Drug prices keep rising amid political pressure, but not as fast
10 September 2019 - Prices for the majority of drugs in the U.S. have started to rise more slowly, likely ...
Posted by Michael Wonder on 10 Sep 2019
Xeris Pharmaceuticals receives U.S. FDA approval for Gvoke (glucagon), the first ready-to-use stable liquid glucagon for severe hypoglycaemia
10 September 2019 - First approval for Xeris is based on positive efficacy and safety results from multiple clinical studies. ...
Posted by Michael Wonder on 10 Sep 2019
Why do post-marketing drug studies required by the FDA take so long?
10 September 2019 - Often times when a new drug is approved by the FDA, the agency requires more studies be ...
Posted by Michael Wonder on 10 Sep 2019
Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them
10 September 2019 - Before he interviewed with President Trump last week to become FDA commissioner, Dr. Stephen Hahn had ...
Posted by Michael Wonder on 10 Sep 2019
More Americans went without health insurance last year. It's the first increase in almost a decade.
10 September 2019 - The proportion of Americans without health insurance edged up in 2018 — the first increase in ...
Posted by Michael Wonder on 10 Sep 2019
Greg Hunt's medical deals come back to bite him
11 September 2019 - Health minister Greg Hunt’s efforts to rein in growth in private health insurance premiums looks like ...
Posted by Michael Wonder on 10 Sep 2019
Canada releases final amendments to patented medicines pricing regulations
9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...
Posted by Michael Wonder on 10 Sep 2019
ICER's blasted pharma pricing for years, but now drug makers are 'rolling up their sleeves' to cooperate
10 September 2019 - Sanofi and Regeneron's next-gen cholesterol drug Praluent never lived up to early expectations, and its price ...
Posted by Michael Wonder on 10 Sep 2019
Horizon Therapeutics announces the FDA has granted priority review of the teprotumumab biologics license application for the treatment of active thyroid eye disease
9 September 2019 - If approved, teprotumumab would be the first FDA approved medicine for this vision-threatening disease. ...
Posted by Michael Wonder on 10 Sep 2019
ProQR receives fast track designation from FDA for QR-1123 for autosomal dominant retinitis pigmentosa
9 September 2019 - ProQR Therapeutics today announced that it received fast track designation from the FDA for QR-1123. ...
Posted by Michael Wonder on 10 Sep 2019
FDA grants fast track status to Amplyx Pharmaceuticals for IV and oral formulations of fosmanogepix (APX001) for seven different indications
9 September 2019 - -- Amplyx Pharmaceuticals announced today that the U.S. FDA has granted fast track designations for both ...
Posted by Michael Wonder on 10 Sep 2019
Pelosi drug pricing plan would let government negotiate most costly medicines
9 September 2019 - The government would be allowed to directly negotiate the prices for some of the most expensive ...
Posted by Michael Wonder on 09 Sep 2019
Reeling from scandal, Novartis vows to voluntarily release info on manipulated data in the future
9 September 2019 - Seeking to appease angry regulators, Novartis committed to notifying the FDA within five business days of ...
Posted by Michael Wonder on 09 Sep 2019
Bernie Sanders went to Canada, and a dream of ‘Medicare for all’ flourished
9 September 2019 - The Vermont senator has staked his presidential campaign, and much of his political legacy, on transforming health ...